Ricardo Azziz

Q: What Schools Are Affiliated With Ricardo Azziz

Ricardo Azziz is affiliated with the following schools: University of Alabama, University at Albany, SUNY, Albany Medical College, Augusta University, University of California, Los Angeles, University of California, Riverside, University of Alabama at Birmingham

Ricardo Azziz's AcademicInfluence.com Rankings

Ricardo Azziz

Medical

#1461

World Rank

#1801

Historical Rank

Public Health

#190

World Rank

#198

Historical Rank

Epidemiology

#214

World Rank

#228

Historical Rank

medical Degrees

Ricardo Azziz

Philosophy

#4578

World Rank

#7152

Historical Rank

Logic

#1989

World Rank

#2878

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Ricardo Azziz's Degrees

Masters Business Administration University of Alabama at Birmingham
Masters Public Health University of Alabama at Birmingham
PhD Epidemiology University of Alabama at Birmingham

Why Is Ricardo Azziz Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ricardo Azziz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Polycystic ovary syndrome (2016) (2741)
The prevalence and features of the polycystic ovary syndrome in an unselected population. (2004) (2522)
Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. (1998) (1774)
Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. (2006) (1679)
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. (2009) (1670)
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. (2010) (1132)
Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. (2007) (1103)
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis (2011) (1073)
Androgen excess in women: experience with over 1000 consecutive patients. (2004) (799)
Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. (2006) (661)
Criteria, prevalence, and phenotypes of polycystic ovary syndrome. (2016) (595)
Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. (2001) (589)
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome†‡ (2018) (587)
Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. (2005) (538)
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome (2018) (515)
Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. (1999) (478)
Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. (2008) (461)
Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. (2005) (448)
Consensus on infertility treatment related to polycystic ovary syndrome (2008) (448)
Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. (2006) (434)
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. (2002) (397)
Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. (2001) (355)
Polycystic ovary syndrome. (2014) (332)
Adenomyosis: current perspectives. (1989) (330)
Impact of obesity on the risk for polycystic ovary syndrome. (2008) (329)
Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). (1998) (303)
Visually scoring hirsutism. (2010) (287)
Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations (2015) (286)
Clinical review 56: Nonclassic adrenal hyperplasia: current concepts. (1994) (265)
Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. (2005) (256)
The evaluation and management of hirsutism. (2003) (248)
Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS) (2005) (227)
Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. (1999) (214)
miRNA-93 Inhibits GLUT4 and Is Overexpressed in Adipose Tissue of Polycystic Ovary Syndrome Patients and Women With Insulin Resistance (2013) (213)
Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. (2006) (196)
Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome. (2005) (195)
Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. (2006) (182)
21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. (2000) (166)
Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis. (1998) (161)
Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts (2011) (159)
21-Hydroxylase deficiency in female hyperandrogenism: screening and diagnosis. (1989) (156)
Diagnostic criteria for polycystic ovary syndrome: a reappraisal. (2005) (155)
Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia. (2007) (150)
Role of diet in the treatment of polycystic ovary syndrome. (2006) (146)
Use of metformin in polycystic ovary syndrome. (2008) (143)
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study. (2005) (140)
Measurement of total serum testosterone levels using commercially available kits: high degree of between-kit variability. (1998) (139)
Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated. (2004) (137)
Diagnosis of Polycystic Ovary Syndrome (2007) (137)
Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. (2010) (137)
Difference in dietary intake between women with polycystic ovary syndrome and healthy controls. (2006) (134)
Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. (2013) (133)
Epigenetic Mechanism Underlying the Development of Polycystic Ovary Syndrome (PCOS)-Like Phenotypes in Prenatally Androgenized Rhesus Monkeys (2011) (130)
CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11 beta-hydroxylase deficiency. (1997) (128)
Reproductive endocrinologic alterations in female asymptomatic obesity. (1989) (126)
Effects of aging on adrenal function in the human: responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women. (2000) (124)
DHEA, DHEAS and PCOS (2015) (122)
PCOS: a diagnostic challenge. (2004) (120)
Hyperandrogenemia in patients presenting with acne. (2001) (119)
Polycystic ovary syndrome: an ancient disorder? (2011) (118)
Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama. (1998) (117)
Androgen excess is the key element in polycystic ovary syndrome. (2003) (112)
Polycystic Ovary Syndrome. (2018) (111)
The adrenal and polycystic ovary syndrome (2007) (109)
Microsurgery alone or with INTERCEED Absorbable Adhesion Barrier for pelvic sidewall adhesion re-formation. The INTERCEED (TC7) Adhesion Barrier Study Group II. (1993) (104)
Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women. (2017) (104)
Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. (2006) (104)
Epigenetics in polycystic ovary syndrome: a pilot study of global DNA methylation. (2010) (101)
Elevated interleukin-6 levels in peritoneal fluid of patients with pelvic pathology. (1992) (100)
Defining hirsutism in Chinese women: a cross-sectional study. (2011) (100)
Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis. (2016) (97)
Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome. (2008) (97)
Anti-Müllerian Hormone in PCOS: A Review Informing International Guidelines (2019) (96)
Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol a in polycystic ovary syndrome: a case–control study (2014) (94)
Polycystic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance. (2005) (94)
Nonclassic Congenital Adrenal Hyperplasia (2010) (94)
Testing and interpreting measures of ovarian reserve: a committee opinion. (2020) (91)
Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study. (1999) (91)
The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia. (2010) (90)
FTO and MC4R Gene Variants Are Associated with Obesity in Polycystic Ovary Syndrome (2011) (89)
Adrenal androgen excess in hyperandrogenism: relation to age and body mass. (1999) (89)
DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE). (2010) (89)
MicroRNA-223 Expression Is Upregulated in Insulin Resistant Human Adipose Tissue (2015) (88)
Introduction: Determinants of polycystic ovary syndrome. (2016) (85)
Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis (2012) (85)
Pro-453 to Ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency. (1992) (85)
Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women. (2006) (84)
Systems Genetics Reveals the Functional Context of PCOS Loci and Identifies Genetic and Molecular Mechanisms of Disease Heterogeneity (2015) (84)
Favourable metabolic effects of a eucaloric lower‐carbohydrate diet in women with PCOS (2013) (83)
Androgen excess: Investigations and management. (2016) (82)
The prevalence of androgen excess among patients with minimal unwanted hair growth. (2004) (82)
Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome. (2003) (81)
A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype. (2000) (80)
Novel Pathway of Adipogenesis through Cross-Talk between Adipose Tissue Macrophages, Adipose Stem Cells and Adipocytes: Evidence of Cell Plasticity (2011) (80)
Resistin Stimulation of 17α-Hydroxylase Activity in Ovarian Theca Cells in Vitro: Relevance to Polycystic Ovary Syndrome (2005) (78)
11β-Hydroxylase deficiency in hyperandrogenism * † (1991) (77)
Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism. (1997) (76)
Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative (2010) (76)
Androgen excess disorders in women (2007) (76)
Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists. Alabama Professional Electrology Association Study Group. (1999) (75)
Family history as a risk factor for the polycystic ovary syndrome. (2000) (74)
Stein and Leventhal: 80 years on. (2016) (72)
Congenital adrenal hyperplasia: long-term results following vaginal reconstruction. (1986) (71)
Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study. (1995) (69)
Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome. (2012) (69)
Prospective Association of Polycystic Ovary Syndrome With Coronary Artery Calcification and Carotid-Intima-Media Thickness: The Coronary Artery Risk Development in Young Adults Women’s Study (2014) (69)
Laser hair reduction in the hirsute patient: a critical assessment. (2002) (69)
Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess. (2004) (67)
Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone. (2003) (66)
Degree of hyperinsulinemia, independent of androgen levels, is an important determinant of the severity of hirsutism in PCOS. (2009) (66)
Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome. (2009) (66)
Socioeconomic and racial predictors of undergoing laparoscopic hysterectomy for selected benign diseases: analysis of 341487 hysterectomies. (2008) (65)
Idiopathic hirsutism. (2000) (62)
Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome. (2016) (62)
The age-associated decline of androgens in reproductive age and menopausal Black and White women. (2007) (60)
Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals. (2015) (60)
Identification and characterization of cytosolic sulfotransferases in normal human endometrium. (1998) (58)
PCOS in 2015: New insights into the genetics of polycystic ovary syndrome (2016) (57)
Genital anomalies in childhood. (1987) (57)
Laparoscopic surgery for ectopic pregnancies: technology assessment and public health implications. (1993) (57)
Effects of a eucaloric reduced-carbohydrate diet on body composition and fat distribution in women with PCOS. (2014) (57)
Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation. (1995) (56)
The severity of menstrual dysfunction as a predictor of insulin resistance in PCOS. (2013) (56)
Acute adrenocorticotropin-(1-24) (ACTH) adrenal stimulation in eumenorrheic women: reproducibility and effect of ACTH dose, subject weight, and sampling time. (1990) (52)
Congenital adrenal hyperplasia. (2011) (51)
21-hydroxylase-deficient nonclassic adrenal hyperplasia: the great pretender. (2003) (51)
A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency (2010) (51)
Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-{alpha}. (2010) (51)
3β-Hydroxysteroid dehydrogenase deficiency in hyperandrogenism (1993) (50)
Heritability and the risk of developing androgen excess (1999) (49)
Laparoscopic evaluation following failure to achieve pregnancy after ovulation induction with clomiphene citrate. (2003) (49)
Polycystic ovary syndrome, insulin resistance, and molecular defects of insulin signaling. (2002) (49)
Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndrome (2018) (48)
Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome (2008) (48)
Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome. (2014) (48)
Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome. (2007) (47)
Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee. (2019) (47)
Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome. (2011) (47)
Reanalyzing the modified Ferriman-Gallwey score: is there a simpler method for assessing the extent of hirsutism? (2009) (47)
Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess. (2005) (47)
A pilot randomized, single-blind, placebo-controlled trial of traditional acupuncture for vasomotor symptoms and mechanistic pathways of menopause (2012) (47)
Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1-24) stimulation in hyperandrogenic women. (1995) (47)
Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level. (1999) (46)
Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria. (2014) (45)
Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome. (2004) (45)
Genetics of polycystic ovary syndrome (2017) (45)
The effects of prolonged hypertestosteronemia on adrenocortical biosynthesis in oophorectomized women. (1991) (45)
Role of the ovary in the adrenal androgen excess of hyperandrogenic women. (1998) (45)
Socioeconomic status and polycystic ovary syndrome. (2011) (44)
Promoting Residents' Professional Development and Academic Productivity Using a Structured Faculty Mentoring Program (2010) (43)
The Development of the Polycystic Ovary Syndrome: Family History as a Risk Factor (1998) (43)
Influence of insulin and testosterone on adrenocortical steroidogenesis in vitro: preliminary studies. (2001) (43)
Adenomyosis in pregnancy. A review. (1986) (42)
PCOS in 2015: New insights into the genetics of polycystic ovary syndrome (2016) (42)
Practical Manual of Operative Laparoscopy and Hysteroscopy (1997) (40)
From the eye of the nurses: 360‐degree evaluation of residents (2009) (40)
The Effect of 17β-Estradiol on Adrenocortical Sensitivity, Responsiveness, and Steroidogenesis in Postmenopausal Women1 (1998) (39)
Role of a CYP17 polymorphism in the regulation of circulating dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome. (2004) (39)
Perspectives on Polycystic Ovary Syndrome: Is Polycystic Ovary Syndrome Research Underfunded? (2017) (38)
Adrenocortical secretion of dehydroepiandrosterone in healthy women: highly variable response to adrenocorticotropin. (2001) (38)
Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome. (2009) (38)
Association study of four key folliculogenesis genes in polycystic ovary syndrome (2010) (37)
Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE). (2009) (36)
Repeated freezing and thawing does not generally alter assay results for several commonly studied reproductive hormones. (2001) (36)
Polycystic Ovary Syndrome Is Associated with an Increased Prevalence of Irritable Bowel Syndrome (2010) (36)
The role of the adrenal cortex in polycystic ovary syndrome. (2001) (36)
On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism. (1990) (36)
The development and use of a standard symphysial‐fundal height growth curve in the prediction of small for gestational age neonates (1988) (35)
The expression of the miR-25/93/106b family of micro-RNAs in the adipose tissue of women with polycystic ovary syndrome. (2014) (35)
How prevalent is metabolic syndrome in women with polycystic ovary syndrome? (2006) (35)
Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource. (2019) (35)
Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome. (2007) (35)
The time has come to simplify the evaluation of the hirsute patient. (2000) (34)
FSH Beyond Fertility (2019) (33)
Complex diseases and co-morbidities: polycystic ovary syndrome and type 2 diabetes mellitus (2019) (33)
Berberine inhibits the proliferation of human uterine leiomyoma cells. (2015) (32)
Postoperative recuperation: relation to the extent of endoscopic surgery. (1989) (32)
First Evidence of Genetic Association Between AKT2 and Polycystic Ovary Syndrome (2008) (32)
Molecular abnormalities of the 21-hydroxylase gene in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to short-term adrenal stimulation. (1995) (32)
Examination of the chin or lower abdomen only for the prediction of hirsutism. (2000) (32)
Risks for Gestational Diabetes Mellitus and Pregnancy-Induced Hypertension Are Increased in Polycystic Ovary Syndrome (2013) (32)
Resistin stimulation of 17alpha-hydroxylase activity in ovarian theca cells in vitro: relevance to polycystic ovary syndrome. (2005) (31)
Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome. (2004) (31)
Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the Androgen Excess and PCOS Society. (2010) (31)
Polycystic Ovarian Syndrome: Long-Term Health Consequences (2017) (31)
The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: a report from the Los Angeles Atherosclerosis Study. (2010) (30)
Association study of CYP17 and HSD11B1 in polycystic ovary syndrome utilizing comprehensive gene coverage. (2012) (30)
Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome. (2011) (30)
O-16:Fifteen-year trend in the inpatient utilization of female reproductive surgery: Analysis of the nationwide inpatient sample (NIS) of the healthcare cost and utilization project (2006) (30)
Negative association between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome? A systematic review and meta-analysis. (2012) (30)
Evolutionary determinants of polycystic ovary syndrome: part 2. (2016) (29)
Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: Pregnancy-Related and Long-Term Health Consequences. (2021) (29)
Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters. (2006) (29)
Effect of obesity on the response to acute adrenocorticotropin stimulation in eumenorrheic women. (1991) (28)
Altered autophosphorylation of the insulin receptor in the ovary of a woman with polycystic ovary syndrome. (2001) (28)
Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene. (2009) (28)
Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA), a candidate gene for polycystic ovary syndrome. (2008) (27)
Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease. (2008) (27)
The Polycystic Ovary Syndrome: Current Concepts On Pathogenesis And Clinical Care (2007) (27)
Effects of endogenous androgens and abdominal fat distribution on the interrelationship between insulin and non-insulin-mediated glucose uptake in females. (2013) (27)
Ovarian hormones and adrenal androgens during a woman's life span. (2001) (27)
Nonreplication of the type 5 17beta-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome. (2008) (26)
Erratum: PCOS in 2015: New insights into the genetics of polycystic ovary syndrome (Nature Reviews Endocrinology (2016) 12 (7475)) DOI:10.1038/nrendo.2015.230) (2016) (26)
Adrenocortical hyperresponsivity to adrenocorticotropic hormone: a mechanism favoring the normal production of cortisol in 21-hydroxylase-deficient nonclassic adrenal hyperplasia. (2000) (25)
Dopamine D3 receptor polymorphism is not associated with the polycystic ovary syndrome. (1999) (25)
Advances in the diagnosis and treatment of the hirsute patient. (1995) (25)
DHEA-S Levels and Cardiovascular Disease Mortality in Postmenopausal Women: Results From the National Institutes of Health—National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Womenʼs Ischemia Syndrome Evaluation (WISE) (2011) (25)
Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3. (2008) (25)
The treatment of hyperandrogenism with oral contraceptives. (1989) (25)
Prevalence of 21-hydroxylase-deficient nonclassic adrenal hyperplasia and insulin resistance among hirsute women from Puerto Rico. (2000) (24)
Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome. (2008) (24)
Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility. (2012) (23)
The hyperandrogenic-insulin-resistant acanthosis nigricans syndrome: therapeutic response. (1994) (23)
FEM1A and FEM1B: novel candidate genes for polycystic ovary syndrome. (2008) (23)
Polycystic ovary syndrome is a family affair. (2008) (22)
A variant of the glucocorticoid receptor gene is not associated with adrenal androgen excess in women with polycystic ovary syndrome. (2000) (22)
Berberine regulates the protein expression of multiple tumorigenesis-related genes in hepatocellular carcinoma cell lines (2017) (21)
Metabolic and cardiovascular genes in polycystic ovary syndrome: A candidate-wide association study (CWAS) (2012) (21)
The effect of 17 beta-estradiol on adrenocortical sensitivity, responsiveness, and steroidogenesis in postmenopausal women. (1998) (21)
Regulation of extragonadal insulin-like growth factor-binding protein-3 by testosterone in oophorectomized women. (1994) (20)
Adrenal Androgens and Reproductive Aging in Females (1991) (20)
Essential Reproductive Medicine (2004) (20)
Minimal difference in phenotype between adolescents and young adults with polycystic ovary syndrome. (2019) (20)
Prevalence of hyperandrogenemia among nonhirsute oligo-ovulatory women. (1997) (20)
Polycystic ovary syndrome: what's in a name? (2014) (20)
Adrenal androgen production in response to adrenocorticotropin infusions in men. (1996) (20)
Use of an oxidized, regenerated cellulose absorbable adhesion barrier at laparoscopy. (1991) (20)
Abnormalities of 21-hydroxylase gene ratio and adrenal steroidogenesis in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to acute adrenal stimulation. (1991) (20)
Effect of oral estrogen on substrate utilization in postmenopausal women. (2008) (19)
Prevalence of 3beta-hydroxysteroid dehydrogenase-deficient nonclassic adrenal hyperplasia in hyperandrogenic women with adrenal androgen excess. (1999) (18)
Non-classic adrenal hyperplasia in hyperandrogenism: A reappraisal (1998) (18)
The pressing need for standardization in epidemiologic studies of PCOS across the globe (2019) (18)
The 21-Hydroxylase-Deficient Adrenal Hyperplasias: More Than ACTH Oversecretion (1996) (18)
No acute effect of physiological insulin increase on dehydroepiandrosterone sulfate in women with obesity and/or polycystic ovarian disease. (1991) (18)
Effect of oral micronized progesterone on androgen levels in women with polycystic ovary syndrome. (2002) (18)
Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome. (1997) (17)
Preliminary evidence of glycogen synthase kinase 3 beta as a genetic determinant of polycystic ovary syndrome. (2007) (16)
LEUPROLIDE AND ESTROGEN VERSUS ORAL CONTRACEPTIVE PILLS FOR THE TREATMENT OF HIRSUTISM : A PROSPECTIVE RANDOMIZED STUDY (1996) (16)
Magnetic resonance imaging of the adrenal gland in women with late-onset adrenal hyperplasia. (1991) (16)
Correlation of adrenocorticotropin steroid levels between women with polycystic ovary syndrome and their sisters. (2007) (16)
The Associations Between Residents' Behavior and the Thomas-Kilmann Conflict MODE Instrument. (2010) (16)
Collaborations , alliances and mergers Mergers in Higher Education : A Proactive Strategy to a Better Future ? (2017) (16)
11beta-hydroxyandrostenedione and delta5-androstenediol as markers of adrenal androgen production in patients with 21-hydroxylase-deficient nonclassic adrenal hyperplasia. (1999) (16)
Steroidogenic acute regulatory protein (StAR) in the ovaries of healthy women and those with polycystic ovary syndrome. (2001) (16)
Differential binding of estradiol and testosterone to SHBG. Relation to circulating estradiol levels. (1998) (15)
Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome (2016) (15)
Identifying and Developing Leadership Competencies in Health Research Organizations: A Pilot Study. (2012) (14)
Acute myometritis and chorioamnionitis during cesarean section of asymptomatic women. (1988) (14)
Does the risk of diabetes and heart disease in women with polycystic ovary syndrome lessen with age? (2017) (14)
Genetic basis of eugonadal and hypogonadal female reproductive disorders. (2017) (13)
Effect of insulin and testosterone on androgen production and transcription of SULT2A1 in the NCI-H295R adrenocortical cell line. (2009) (13)
PCOS: Animal models for PCOS — not the real thing (2017) (13)
Family size in women with polycystic ovary syndrome. (2006) (13)
Basal metabolic rate in women with PCOS compared to eumenorrheic controls (2015) (13)
A twenty-first century research agenda for polycystic ovary syndrome. (2006) (13)
11 beta-hydroxylase deficiency in hyperandrogenism. (1991) (12)
Environmental Pollutant Benzo[a]pyrene Induces Recurrent Pregnancy Loss through Promoting Apoptosis and Suppressing Migration of Extravillous Trophoblast (2020) (12)
Harnessing Expression Data to Identify Novel Candidate Genes in Polycystic Ovary Syndrome (2011) (12)
Adrenal progestogen and androgen production in 21-hydroxylase-deficient nonclassic adrenal hyperplasia is partially independent of adrenocorticotropic hormone stimulation. (2002) (12)
Facial and abdominal hair growth in hirsutism: a computerized evaluation. (2001) (12)
Racial and ethnic differences in the metabolic response of polycystic ovary syndrome (2020) (12)
Early Adrenarche in Normal Prepubertal Girls: A Prospective Longitudinal Study (2004) (11)
Association study of androgen signaling pathway genes in polycystic ovary syndrome. (2016) (11)
Effect of bilateral oophorectomy on adrenocortical function in women with polycystic ovary syndrome. (2013) (11)
Adipocyte Insulin Resistance In PCOS: Relationship With GLUT-4 Expression, Whole-Body Glucose Disposal, β-Cell Function. (2020) (11)
Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion. (2020) (11)
We should avoid the indiscriminate use of insulin sensitizers in women with polycystic ovary syndrome. (2003) (11)
Definition, Diagnosis, and Epidemiology of the Polycystic Ovary Syndrome (2007) (11)
Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism. (2021) (11)
Diagnosing the diagnosis: why we must standardize the defining features of polycystic ovary syndrome (2008) (10)
21-hydroxylase-deficient nonclassic adrenal hyperplasia (1995) (10)
Androgen excess disorders (2012) (10)
FTO and MC 4 R Gene Variants Are Associated with Obesity in Polycystic Ovary Syndrome (2015) (10)
Comprehensive assessment of expression of insulin signaling pathway components in subcutaneous adipose tissue of women with and without polycystic ovary syndrome (2015) (10)
Pseudogene/functional gene ratio in late-onset 21-hydroxylase-deficient adrenal hyperplasia. (1990) (10)
The effectiveness of the interview for predicting the presence of polycystic ovary syndrome (2003) (10)
Operative endoscopy: the pressing need for a structured training and credentialing process. (1992) (9)
Impact of architectural disruption on adrenocortical steroidogenesis in vitro. (1999) (9)
3 beta-hydroxysteroid dehydrogenase deficiency in hyperandrogenism. (1993) (9)
Role of reproductive surgeons and the Society of Reproductive Surgeons. (2002) (9)
Adipocyte expression of glucose transporter 1 and 4 in PCOS: Relationship to insulin‐mediated and non–insulin‐mediated whole‐body glucose uptake (2019) (9)
Serum complexed and free prostate-specific antigen (PSA) for the diagnosis of the polycystic ovarian syndrome (PCOS) (2017) (9)
Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy. (1998) (8)
∆5-Androstene-3β,17β-diol in healthy eumenorrheic women: relationship to body mass and hormonal profile * † (1994) (8)
Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome. (2010) (8)
Corrigendum: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations (2016) (8)
Disparities in cardio-metabolic risk between Black and White women with polycystic ovary syndrome: a systematic review and meta-analysis. (2020) (8)
Advantages and Disadvantages of Operative Endoscopy (1992) (7)
Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome. (2018) (7)
Polycystic ovary syndrome and ovulation induction. (2003) (7)
Natural history of polycystic ovary syndrome: A systematic review of cardiometabolic outcomes from longitudinal cohort studies (2021) (7)
SCREENING FOR androgen excess IN WOMEN: accuracy of self-reported excess body hair growth and menstrual dysfunction. (2020) (7)
Training and Certification in Operative Endoscopy (1992) (7)
Why we need epidemiologic studies of polycystic ovary syndrome in Africa (2018) (7)
Evaluating professionalism, practice-based learning and improvement, and systems-based practice: utilization of a compliance form and correlation with conflict styles. (2010) (7)
Clinical Features of the Polycystic Ovary Syndrome (2006) (7)
Evaluation for Insulin Resistance and Comorbidities Related to Insulin Resistance in Polycystic Ovary Syndrome (2007) (7)
Differential diagnosis of clinically evident hyperandrogenism: experience with over 1000 consecutive patients. (2001) (7)
Fifteen‐year trend in the use of male reproductive surgery: analysis of the healthcare cost and utilization project data (2011) (6)
Overview of Long-Term Morbidity and Economic Cost of the Polycystic Ovary Syndrome (2006) (6)
Reproductive hormone exposure timing and ischemic heart disease: Complicated answers to a simple question. (2010) (6)
Berberine Inhibits Uterine Leiomyoma Cell Proliferation via Downregulation of Cyclooxygenase 2 and Pituitary Tumor-Transforming Gene 1 (2017) (6)
Prevalence of Metabolic Syndrome and Overweight/Obesity amongChinese Women of Childbearing Age: A Cross-Sectional Epidemic Study (2014) (6)
Small leucine-rich proteoglycans (SLRPs) in the endometrium of polycystic ovary syndrome women: a pilot study (2017) (6)
Fifteen-year trend in the use of reproductive surgery in women in the United States. (2009) (6)
Training, Certification, and Credentialing in Gynecologic Operative Endoscopy (1995) (6)
ANDROGEN EXCESS SOCIETY GUIDELINE SYNDROME AS A PREDOMINANTLY HYPERANDROGENIC SYNDROME: AN POSITION STATEMENT: CRITERIA FOR DEFINING POLYCYSTIC OVARY (2006) (6)
Androgen-Insensitivity Syndrome: Long-Term Results of Surgical Vaginal Creation (1990) (5)
Close correlation between hyperandrogenism and insulin resistance in women with polycystic ovary syndrome—Based on liquid chromatography with tandem mass spectrometry measurements (2018) (5)
The predictive value of total testosterone alone for clinical hyperandrogenism in polycystic ovary syndrome. (2020) (5)
Are patients with idiopathic hirsutism (IH) insulin resistant?: Comparing women with IH to body mass index-matched patients with polycystic ovary syndrome (PCOS) and controls (2004) (5)
Pathogenesis of Hyperandrogenism in Polycystic Ovary Syndrome (2008) (5)
What is the value and role of academic medicine in the life of its university? (2014) (5)
Concordance of 21-hydroxylase gene ratio, human leukocyte antigen haplotyping and adrenal testing results in a family with late-onset adrenal hyperplasia. (1993) (5)
Consensus on infertility treatment related to polycystic ovary syndrome (Human Reproduction (2007) 23, (462)) (2008) (5)
Dexamethasone Receptor Levels in Palatal and Lung Fibroblasts of Adult A/J and C57BL/6J Mice: Relationship to Glucocorticoid-Induced Cleft Palate (1990) (5)
The Effect of Diet and Exercise in Women with Polycystic Ovary Syndrome (2015) (5)
Report on the Third Annual Meeting of the Androgen Excess Society, San Diego, California, June 3, 2005. (2006) (4)
The Second International Symposium on the Developmental Aspects of Androgen Excess, Toronto, Canada, 20 June 2000 (2000) (4)
Strategic Mergers in Higher Education (2019) (4)
Reproducibility of the adrenal androgen response to adrenocorticotropic hormone stimulation. (2006) (4)
Prevalence of insulin resistance in Polycystic Ovary Syndrome (PCOS) patients using the Homeostatic Measurement Assessment (HOMA-IR) (2003) (4)
Genes for Enzymes Regulating DHEA Sulfonation are Associated with Levels of DHEA-Sulfate in Polycystic Ovary Syndrome 1 (2007) (4)
Dexamethasone receptor levels in palatal and lung fibroblasts of adult A/J and C57BL/6J mice: relationship to glucocorticoid-induced cleft palate. (1990) (4)
Perspectives: Like Waves in a Tarpit: Academia's Internal Communications Problem (2014) (4)
Nonclassic adrenal hyperplasia. (1997) (3)
An Update on Polycystic Ovary Syndrome (2007) (3)
Screening for androgen excess in women: accuracy of self-reported excess body hair growth and menstrual dysfunction (2019) (3)
How polycystic ovary syndrome came into its own. (2021) (3)
Long-Term Morbidity of PCOS (2007) (3)
PCOS Phenotype in Unselected Populations Study (P-PUP): Protocol for a Systematic Review and Defining PCOS Diagnostic Features with Pooled Individual Participant Data (2021) (3)
O-26: The association of androgen levels with the severity of hirsutism in the polycystic ovary syndrome (PCOS) (2006) (3)
Should employer-sponsored health insurance benefits be made public? (2002) (3)
A faculty and resident development program to improve learning and teaching skills. (2009) (3)
Association study of AMP-activated protein kinase subunit genes in polycystic ovary syndrome. (2009) (3)
Profile of Daughters and Sisters of Women with Polycystic Ovary Syndrome: The Role of Proband's Glucose Tolerance. (2021) (3)
Late onset adrenal hyperplasia: mutation at codon 282 of the functional 21-hydroxylase gene is not ubiquitous. (1990) (3)
P-075 Idiopathic hirsutism (IH): An uncommon cause of hirsutism in Alabama (1997) (3)
Comprehensive Evaluation of Disparities in Cardiometabolic and Reproductive Risk between Hispanic and White Women with Polycystic Ovary Syndrome in the United States: a Systematic Review and Meta-Analysis. (2021) (3)
Demystifying fallacies surrounding nonclassic adrenal hyperplasia (1996) (3)
Establishing Hemostasis at Laparoscopy (1992) (3)
Hypothalamic-Pituitary-Adrenal Dysfunction in the Polycystic Ovary Syndrome (2006) (3)
Authors’ Response: Troglitazone Use in Polycystic Ovary Syndrome (2001) (3)
P-448 : Changes in the outpatient and inpatient utilization of female reproductive surgery, 1998-2002: Analysis of the Healthcare Cost and Utilization Project (2006) (2)
Severe Insulin-Resistance Hyperandrogenic Syndromes (2006) (2)
FEM 1 A and FEM 1 B : novel candidate genes for polycystic ovary syndrome (2008) (2)
Definition and Epidemiology of the Polycystic Ovary Syndrome (2006) (2)
Adrenocortical Dysfunction in the Polycystic Ovary Syndrome (1996) (2)
Sexual function and polycystic ovary syndrome: a systematic review and meta-analysis (2016) (2)
Alterations in plasma non-esterified fatty acid (NEFA) kinetics and relationship with insulin resistance in polycystic ovary syndrome (2019) (2)
Fertility and infertility: Editorial overview (1992) (2)
Practical Manual of Operative Laparoscopy and Hysteroscopy (1992) (2)
POLYCYSTIC OVARY SYNDROME Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome (2009) (2)
Health System Creation and Integration at a Health Sciences University: A Five-Year Follow-up (2017) (2)
Differential Diagnosis and Evaluation of Hyperandrogenism (2003) (2)
The Nonclassic Adrenal Hyperplasias (2006) (2)
Evaluation of infertility : A cost effective approach (1997) (2)
Presidential and Academic Health Center Leadership within the Modern University: Opportunities and Challenges (2015) (2)
Change in the diagnosis of patients with idiopathic hirsutism (IH) to Polycystic Ovary Syndrome (PCOS) due to the use of the 2003 Rotterdam criteria (2004) (2)
AKT2 : First Evidence of Genetic Association with Polycystic Ovary Syndrome (2008) (2)
History of Polycystic Ovary Syndrome, Premature Adrenarche, and Hyperandrogenism in Pediatric Endocrinology (2022) (2)
delta 5-Androstene-3 beta,17 beta-diol in healthy eumenorrheic women: relationship to body mass and hormonal profile. (1994) (2)
A Brief History of Androgen Excess (2006) (2)
Training, certification, and credentialing in gynecologic operative endoscopy. (1995) (2)
The Degree of Menstrual Disturbance Is Associated With the Severity of Insulin Resistance in PCOS (2021) (2)
Amenorrhea, Oligomenorrhea, and Hyperandrogenic Disorders (2010) (1)
Review Article Nonclassic Congenital Adrenal Hyperplasia (2010) (1)
Women's Health: Advances in the evaluation and treatment of unwanted hair growth (2002) (1)
Abnormal Expression of Genes Involved in Inflammation, Lipid Metabolism, and Wnt Signaling in the Adipose Tissue of Polycystic Ovary Syndrome (2012) (1)
Letter to the editor re: Casarini and Brigante, 2014, from Azziz R., et al. (2015) (1)
Adrenocortical dysfunction in androgen excess (1993) (1)
Triglyceride to high-density lipoprotein cholesterol ratio as a predictor of insulin resistance in women with polycystic ovary syndrome (PCOS) (2011) (1)
Effect of sex steroids and insulin on dehydroepiandrosterone sulfate production by hepatoma G2 cells. (2009) (1)
Anti-mullerian Hormone Receptor Type II Gene Polymorphisms Similar Among Women With the Polycystic Ovary Syndrome (PCOS) and Controls (2009) (1)
Obstetrics and Gynecology: Cases, Questions, and Answers (2006) (1)
Value of 1-hour versus 2-hour insulin levels during the oral glucose tolerance test (OGTT) for identifying the degree of hyperinsulinemia (HI) in PCOS women (2010) (1)
Laparoscopic Ovarian and Parovarian Surgery (1997) (1)
POLYCYSTIC OVARY SYNDROME (PCOS): A DIAGNOSTIC CHALLENGE (2004) (1)
O-078 Genotype and phenotype in women with 21-hydroxylase (21-OH) deficient non-classic adrenal hyperplasia (NCAH) (1997) (1)
Pcos And Mendelian Randomization: Too Soon? (2021) (1)
Adiposity in polycystic ovary syndrome: excess versus dysfunction. (2021) (1)
[Infertility treatment before assisted reproductive techniques]. (2001) (1)
Pregnancy-related economic burden of polycystic ovary syndrome (PCOS) (2019) (1)
Abstract 4178: Cardiovascular Event-Free Survival in Post-Menopausal Women with Polycystic Ovary Syndrome: Results from the Women's Ischemia Syndrome Evaluation (2006) (1)
Metabolic features of adult and adolescent first-degree relatives of women with polycystic ovary syndrome: a systematic review and meta-analysis (2017) (1)
Clinical and Hormonal Evaluation of Androgen Excess (2006) (1)
Where are we in understanding the natural history of polycystic ovary syndrome? A systematic review of longitudinal cohort studies (2022) (1)
PostersReproductive Endocrinology (i.e. PCOS, Menarche, Menopause etc.) (2010) (1)
The different phenotypes of the polycystic ovary syndrome (PCOS). (2001) (1)
Women with polycystic ovary syndrome (PCOS) have lower basal metabolic rates compared to eumenorrheic controls (2013) (1)
Hormonal and Metabolic Factors Influence the Action of Progesterone on the Endometrium of Women with Polycystic Ovary Syndrome (2023) (1)
Differential binding of and testosterone to SHBG: Relation to circulating estradiol levels (1998) (1)
The clinical management of Hirsutism: evidence based practice (2004) (1)
Implementing a teaching service for voluntary faculty in obstetrics and gynecology: long-term results. (2013) (1)
Why can’t a man be more like a mouse?: Reply of the authors (2001) (1)
Reply: How many of the items in the polycystic ovary syndrome can be validated statistically? (2006) (1)
Letter to the Editor: "Type B Insulin Resistance Masquerading as Ovarian Hyperthecosis". (2017) (1)
Detection of CAH heterozygotes [5] (multiple letters) (1997) (1)
Systemic chronic subclinical inflammation, adipose tissue dysfunction, and polycystic ovary syndrome: three major forces intertwined. (2021) (1)
Publisher Correction: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations (2020) (1)
Obituary for John Benjamin Younger, Sr., M.D. (2003) (1)
Giving Feedback (The Good and the Bad) (2009) (1)
Laparoscopic Uterine Nerve Ablation, Presacral Neurectomy, and Appendectomy (1992) (1)
Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS) using age-specific DHEAS levels adjusted for body mass and ethnicity (2003) (1)
Defining what is normal: the key to the diagnosis of polycystic ovary syndrome (and any other disorder for that matter…). (2019) (1)
Photo and Video Documentation in Endoscopic Surgery (1997) (1)
Erratum to: Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis (2012) (0)
Atlas of Female Infertility Surgery, 2nd ed, R.B. Hunt. Mosby Yearbook Inc, Baltimore (MD) (1992), 1, Price $129.00 (1994) (0)
Sexual function in polycystic ovary syndrome: a systematic review and meta-analysis (2016) (0)
A Comparison of Insulin Action Between Women With 21-Hydroxy- lase-Deficient Nonclassic Adrenal Hyperplasia (NCAH) and Polycystic (2005) (0)
EVALUATING OVARIAN VOLUME AS A SINGLE MARKER FOR POLYCYSTIC OVARY SYNDROME (PCOS) AND METABOLIC DYSFUNCTION (2020) (0)
The severity of menstrual dysfunction serves as a predictor of insulin resistance in the polycystic ovary syndrome (PCOS) (2010) (0)
P-869: Combination suppressive therapy in the polycystic ovary syndrome (PCOS): Predictors of success (2006) (0)
Second international symposium on the developmental aspects of androgen excess disorders: Preface (2000) (0)
The synergistic effects of co-culture on adiponectin secretion in polycystic ovary syndrome (2008) (0)
The Hispanic patient. (1981) (0)
Endocrine Society MTP Diagnosis and Management of Androgen Excess (2015) (0)
Adenomyosis, Leiomyomata, and Pelvic Pain (1998) (0)
Visually quantifying normal and abnormal hair growth in women (2009) (0)
Co-culture of adipocytes and resident macrophages affects monocyte chemoattractant protein-1 secretion in polycystic ovary syndrome (2007) (0)
PMON247 Prevalence of Polycystic Ovary Syndrome in Eastern Siberia: a Cross-Sectional Study. (2022) (0)
Publisher Correction: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations (2020) (0)
3β-Hydroxysteroid Dehydrogenase Deficient NCAH: A Myth or Reality? (2006) (0)
Black Women Have a Worse Cardio-Metabolic Risk Profile Compared to White Women with Polycystic Ovary Syndrome in the United States: A Systematic Review and Meta-Analysis (2021) (0)
Reply of the Authors: Criteria for the polycystic ovary syndrome (2009) (0)
Polycystic Ovary Syndrome: Adrenocortical dysfunction in polycystic ovary syndrome (2007) (0)
Adrenal androgens in the polycystic ovary syndrome (2002) (0)
Use of fasting blood glucose levels to detect the presence of glucose intolerance in polycystic ovary syndrome (PCOS) (2010) (0)
Replication of Genetic Variants for Polycystic Ovary Syndrome (PCOS) In a European Cohort (2014) (0)
The glucose to insulin ratio (GIR) is useful predicting insulin resistance (IR) only in obese, but not non‐obese, women with hyperandrogenism (HA) (2000) (0)
Exploring the relationship between PCOS and Type 2 diabetes mellitus (2002) (0)
Abstract 5025: Transition to Menopause and Preclinical Atherosclerosis in Women: A Report from the Los Angeles Atherosclerosis Study (LAAS) (2008) (0)
Berberine regulates the protein expression of multiple tumorigenesis-related genes in hepatocellular carcinoma cell lines (2017) (0)
Acute myometritis and chorioamnionitis during cesarean section of asymptomatic women (1989) (0)
423 GENETIC VARIATION IN 5α-REDUCTASE INFLUENCES DEVELOPMENT OF POLYCYSTIC OVARY SYNDROME AND SEVERITY OF HIRSUTISM. (2006) (0)
Artist’s Statement: Paranoia (2014) (0)
PCOS and normal menses: Another point of view (2003) (0)
Editor's formulation - The late-onset adrenal hyperplasias: An example of molecular biology applied to the study of androgen excess disorders (1993) (0)
DIFFERENCES IN PCOS PRESENTATION AMONG BLACK WOMEN IN CALIFORNIA AND ALABAMA (2020) (0)
PMON244 Alterations in Nonesterified Free Fatty Acids (NEFA) Trafficking Rather Than Hyperandrogenism Contribute to Variations in Insulin Sensitivity Among Obese Women with Polycystic Ovary Syndrome (2022) (0)
Comprar Obstetrics & Gynecology | Ricardo Azziz | 9780071458207 | Mcgraw-Hill Education (2007) (0)
Is hirsutism a marker of metabolic dysfunction? (2019) (0)
Racial and Ethnic Disparities in Polycystic Ovary Syndrome. (2023) (0)
Abstract 5027: Endogenous and Exogenous Reproductive Hormones and Preclinical Atherosclerosis in Women: The Los Angeles Atherosclerosis Study (LAAS) (2008) (0)
Technology Transfer and Commercialization as a Source for New Revenue Generation for Higher Education Institutions and for Local Economies (2021) (0)
use and metabolic side effects expression: clues to the association between valproate Valproate-induced alterations in human theca cell gene (2015) (0)
The Need to Reassess the Diagnosis of Polycystic Ovary Syndrome (PCOS): A Review of Diagnostic Recommendations from the International Evidence-Based Guideline for the Assessment and Management of PCOS (2021) (0)
Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters (2007) (0)
Goodarzi MO, Jones MR, Chen Y-DI, Azziz R. First evidence of genetic association between AKT2 and polycystic ovary syndrome. Diabetes Care 2008;31:2284-2287 (2009) (0)
Physiology and pathology of adrenal disorders (2002) (0)
Metformin use in polycystic ovary syndrome: metabolic benefits and diabetes prevention. (2008) (0)
New name, school still addressing physician shortages in Georgia. (2011) (0)
Facial hair growth in hirsuite women with polycystic ovary syndrome (PCOS) correlates with hyperinsulinemia (2008) (0)
RF10 | PMON218 Direct Costs of Mental Health Disorders in PCOS: Systematic Review and Meta-Analysis (2022) (0)
The polycystic ovary syndrome: the first 150 years of study (2022) (0)
Direct Economic Burden of Mental Health Disorders Associated with Polycystic Ovary Syndrome: Systematic Review and Meta-analysis (2023) (0)
A Comparison of Insulin Action Between Women With 21-Hydroxylase-Deficient Nonclassic Adrenal Hyperplasia (NCAH) and Polycystic Ovary Syndrome (PCOS) (2005) (0)
Body fat distribution and lean body mass (by CT scan) as a determinant of insulin resistence by FSIVGTT in polycystic ovary syndrome (2010) (0)
Cover Story/CME: Evaluation and treatment of unwanted hair growth (2002) (0)
Editor's formulation: Towards a working classification of androgen excess disorders (1994) (0)
Troglitazone use in polycystic ovary syndrome [letter] [reply] (2001) (0)
and polycystic ovary syndrome?: a systematic review and meta-analysis (2012) (0)
P-870 : Dehydroepiandrosterone sulfate (DHEAS) as a predictor of insulin resistance in patients with polycystic ovary syndrome (PCOS) (2006) (0)
The phenotype of polycystic ovary syndrome (PCOS) in Hispanic vs. non-Hispanic White women (2010) (0)
Sensitivity and responsiveness to ACTH of adrenal secretion of Dehydrocpiandrosterone (DHEA) and cortisol in aging women (1998) (0)
Relationship of ovarian morphology to degree of menstrual cycle dysfunction and insulin resistance in polycystic ovary syndrome (PCOS) (2010) (0)
Family size in the Polycystic Ovary Syndrome (PCOS) (2004) (0)
Is antimüllerian hormone an early marker or an in utero effector of incipient polycystic ovary syndrome? (2019) (0)
Puberty and Disorders of Pubertal development (2010) (0)
Detection of CAH heterozygotes. (1997) (0)
Reply of the Authors: Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome (2009) (0)
Increased total and phosphorylated glycogen synthase kinase-3 (GSK-3) in the adipocytes of patients with the polycystic ovary syndrome (PCOS) (2004) (0)
"Letter to the Editor: Distribution of Body Hair in Young Australian Women and Associations with Serum Androgen Concentrations". (2020) (0)
Comprar Androgen Excess Disorders in Women | Azziz, Ricardo | 9781588296634 | Springer (2007) (0)
Polycystic ovary syndrome, microbiomics and why you should be a little selfish with your time (2013) (0)
PMON245 Clinical Phenotypes of Polycystic Ovary Syndrome (PCOS) in Nigerian Women: Preliminary Results of the Nigeria PCOS Epidemiology & Phenotype (Nigeria-Pep) Study (2022) (0)
Inconclusive results from the study evaluating the use of blunt needles during obstetric laceration repair (2009) (0)
P-868: Prevalence of hyperandrogenemia in the polycystic ovary syndrome (2006) (0)
Comprar Obstetrics & Gynecology | Ricardo Azziz | 9780071100052 | Mcgraw-Hill Education (2007) (0)
JAMA Peer Reviewers for 2003 (2017) (0)
Endocrinology of the Ovary (2005) (0)
BRIEF REPORT The Age-Associated Decline of Androgens in Reproductive Age and Menopausal Black and White Women (2007) (0)
When is late-onset adrenal hyperplasia not late-onset adrenal hyperplasia? (1991) (0)
Establishing Normative Values to Determine the Prevalence of Biochemical Hyperandrogenism in Premenopausal Women of Different Ethnicities from Eastern Siberia (2022) (0)
Reproducibility of adrenal androgen levels and their response to the adrenocorticotropic hormone (ACTH) stimulation test (2004) (0)
Financial fluency: demystifying accounting and business planning for the reproductive medicine specialist. (2020) (0)
Variants in genes involved in androgen signaling as genetic determinants of polycystic ovary syndrome (PCOS) (2010) (0)
Regional Variation in Hormonal and Metabolic Parameters of White and Black Women With PCOS in the United States. (2022) (0)
Electrosurgery and Thermocoagulation at Operative Endoscopy (1997) (0)
Abstract 3649: Menstrual Cycling and Mechanisms of Cardiovascular Disease Events in Post-Menopausal Women: Results from the NIH-NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) (2007) (0)
Ovarian volume as an independent marker for metabolic dysfunction in women with suspected androgen excess (2022) (0)
PMON248 Predictive value of markers of hyperandrogenism in 1610 women with PCOS (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ricardo Azziz?

Ricardo Azziz is affiliated with the following schools:

Ricardo Azziz's Academic­Influence.com Rankings

Ricardo Azziz's Degrees

Why Is Ricardo Azziz Influential?

Ricardo Azziz's Published Works

Published Works

What Schools Are Affiliated With Ricardo Azziz?

Ricardo Azziz's AcademicInfluence.com Rankings